Mechanism for prion diseases unfolds

Accumulation of normal prion protein in the cytosol causes neurodegeneration and conversion to the aberrant form.

Written byNicole Johnston
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The mechanism by which prion proteins trigger progressive neurodegeneration in spongiform encephalopathies such as Creutzfeldt–Jakob disease (CJD) in humans and mad cow disease in cattle is not known. In two papers in the October 17 issue of Science, Susan Lindquist, director of the Whitehead Institute for Biomedical Research, Cambridge, US, and Jiyan Ma, from Ohio State University, give new insights into how prion proteins kill neurons and how the insoluble, aberrant form of the prion protein (PrPSc) arises in the cell.

Mammalian prion (PrP) proteins normally reside on the surface of the cell. But if PrP misfolds during maturation in the endoplasmic reticulum, it is sent to the cytosol via retrograde transport for degradation in the proteasome. If proteasome activity is compromised in any way, however, misfolded PrP accumulates in the cytosol.

"What we were interested in determining is what might be the toxic species and how they might convert," ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies